Patient characteristics associated with relative benefit of esketamine nasal spray versus quetiapine extended release on achieving remission in ESCAPE-TRD study

Neuroscience Applied 2026 Open access

Read full text
Authors: A.J. Oliveira-Maia, B.T. Baune, L. Bartova, Jozefien Buyze, N. Cardoner, A.J. Cleare, Y. Godinov, RE Nielsen, Eduard Vieta, R. S. McIntyre
DOI: 10.1016/j.nsa.2025.106785
Cited by: 0

Fields of Study & Subjects

Treatment of Major Depression Schizophrenia research and treatment Electroconvulsive Therapy Studies

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
106785–106785
Publication date
1 January 2026
Language
EN